[e-drug] Medical Product Quality Report: COVID-19 issues // issue 3

E-DRUG: Medical Product Quality Report: COVID-19 issues // issue 3
---------------------------------------------------------------------

Dear colleagues,
The COVID-19 pandemic is accompanied by a multitude of reports of
substandard and falsified (SF) medical products, ranging from personal
protective equipment to diagnostic tests, medicines, and vaccines. In
response to this, we started a system for collecting, curating, and
visualizing information available in the public domain on quality concerns
related to COVID-19 medical products.

The Medical Product Quality Reports hold reports from scientific literature, public alerts/warnings, and lay press: https://www.iddo.org/mq/research/medical-product-quality-reports

The third issue, covering the month of August 2020 is available now and
shows 62 articles reporting on 72 different incidents/issues of SF products
from searches in Google News.
It is out at
https://www.iddo.org/external-publication/medical-product-quality-report-covid-19-issues-issue-3-august-2020-main-text.

In the USA there are several reports on propanol containing hand
sanitizers. We report on several alerts with masks labeled as 'Made in
Taiwan' that turn out to be falsified and manufactured in China.

Apart from Sputnik V, COVID-19 vaccines are not authorized yet, nevertheless, there are already reports of Chinese trial vaccines being available online. Urgent discussion is needed for optimizing risk-based surveillance to prevent, detect, and respond to the inevitable substandard and falsified vaccines.

Any remarks or additions to content are greatly appreciated (please write
to medicinequality@iddo.org). We would be delighted if you could
disseminate this information within your network.

Very best wishes,

Kerlijn Van Assche, Celine Caillet, Paul N Newton
Medicine Quality Research Group, Infectious Diseases Data Observatory
(IDDO) & Mahidol Oxford Research Unit (MORU), Centre for Tropical Medicine
& Global Health, Nuffield Department of Medicine, University of Oxford,
Oxford, UK
Kerlijn Van Assche <kerlijn.vanassche@iddo.org>